BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21429659)

  • 1. Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf.
    Pitchakarn P; Suzuki S; Ogawa K; Pompimon W; Takahashi S; Asamoto M; Limtrakul P; Shirai T
    Cancer Lett; 2011 Jul; 306(2):142-50. PubMed ID: 21429659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3.
    Pitchakarn P; Suzuki S; Ogawa K; Pompimon W; Takahashi S; Asamoto M; Limtrakul P; Shirai T
    Food Chem Toxicol; 2012 Mar; 50(3-4):840-7. PubMed ID: 22266361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.
    Yim D; Singh RP; Agarwal C; Lee S; Chi H; Agarwal R
    Cancer Res; 2005 Feb; 65(3):1035-44. PubMed ID: 15705905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells.
    Liu H; Liu YQ; Liu YQ; Xu AH; Young CY; Yuan HQ; Lou HX
    Chem Biol Interact; 2010 Dec; 188(3):598-606. PubMed ID: 20692244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells.
    Gupta S; Afaq F; Mukhtar H
    Oncogene; 2002 May; 21(23):3727-38. PubMed ID: 12032841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
    Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
    Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells.
    Zaidman BZ; Wasser SP; Nevo E; Mahajna J
    Int J Oncol; 2007 Oct; 31(4):959-67. PubMed ID: 17786330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
    Lu X; Hsieh TC; Wu JM
    Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
    Qiu J; Gao Z; Shima H
    Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
    Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H
    Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells.
    Deep G; Oberlies NH; Kroll DJ; Agarwal R
    Carcinogenesis; 2007 Jul; 28(7):1533-42. PubMed ID: 17389612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel diterpene suppresses CWR22Rv1 tumor growth in vivo through antiproliferation and proapoptosis.
    Lin FM; Tsai CH; Yang YC; Tu WC; Chen LR; Liang YS; Wang SY; Shyur LF; Chien SC; Cha TL; Hsiao PW
    Cancer Res; 2008 Aug; 68(16):6634-42. PubMed ID: 18701487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
    Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
    Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145.
    Yun JM; Kweon MH; Kwon H; Hwang JK; Mukhtar H
    Carcinogenesis; 2006 Jul; 27(7):1454-64. PubMed ID: 16497706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
    Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ
    Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL; Lin JK
    Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cell growth and induction of apoptosis in human prostate cancer cell lines by 6-aminoquinolone WM13.
    Minelli A; Bellezza I; Siciliano E; Liguori L; Tabarrini O; Cecchetti V; Fravolini A
    Oncol Rep; 2005 Jun; 13(6):1113-20. PubMed ID: 15870930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
    Kim J; Park H; Im JY; Choi WS; Kim HS
    Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
    Ray RB; Raychoudhuri A; Steele R; Nerurkar P
    Cancer Res; 2010 Mar; 70(5):1925-31. PubMed ID: 20179194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.